Meet Frederick (also known as Biff), a cancer patient who has gone through a Bristol-Myers Squibb clinical trial. Biff is a proud grandfather of six and talked to his doctor about whether a clinical trial option was an option for him.
Bristol-Myers Squibb is a proud supporter of the Coast 2 Coast 4 Cancer cross country bike ride. Employees of Bristol-Myers Squibb biked nearly 2,900 miles all in support of raising funds for cancer research.
Discovery is in Nils’ DNA. His fascination with chemistry labs began as child, when he tagged along with his father, who was a graduate student at the University of California. As a graduate student at Harvard, Nils learned about a new technology for manipulating the genome of mammals, and was so intrigued that he continued this field of study in a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in New York. Today, at Bristol-Myers Squibb, Nils leads a drug discovery group responsible for looking for new medicines to help patients overcome serious diseases.
For Joan, hepatitis C is much more than a significant global public health challenge—it’s personal. It has played a role in the story of her family, and it was from her family that she learned the importance of “sticking together,” as well as the importance of the work she and her team does every day.
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. We are exploring new approaches to treat diseases with significant unmet medical need. Through the Bristol-Myers Squibb Foundation, we promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases. Each day, our employees around the world are committed to working together for patients – it drives everything we do.